Thomas Wiegel

1998–2024 年に発表

92
論文数
27,625
被引用数
53
h 指数
87
i10 指数

被引用数

Thomas Wiegel の年別被引用数1985 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 2 件2002 年: 被引用 6 件2003 年: 被引用 3 件2004 年: 被引用 5 件2005 年: 被引用 3 件2006 年: 被引用 6 件2007 年: 被引用 11 件2008 年: 被引用 18 件2009 年: 被引用 20 件2010 年: 被引用 25 件2011 年: 被引用 65 件2012 年: 被引用 135 件2013 年: 被引用 135 件2014 年: 被引用 160 件2015 年: 被引用 189 件2016 年: 被引用 220 件2017 年: 被引用 233 件2018 年: 被引用 231 件2019 年: 被引用 869 件2020 年: 被引用 805 件2021 年: 被引用 819 件2022 年: 被引用 679 件2023 年: 被引用 466 件2024 年: 被引用 904 件2025 年: 被引用 427 件2026 年: 被引用 15 件1986〜1998 年は被引用が無いため表示していません2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,561 件、この内訳の 15.1%ドイツ: 引用元論文 932 件、この内訳の 9%イタリア: 引用元論文 834 件、この内訳の 8.1%中国: 引用元論文 782 件、この内訳の 7.6%イギリス: 引用元論文 701 件、この内訳の 6.8%オランダ: 引用元論文 577 件、この内訳の 5.6%フランス: 引用元論文 485 件、この内訳の 4.7%カナダ: 引用元論文 466 件、この内訳の 4.5%スイス: 引用元論文 371 件、この内訳の 3.6%ベルギー: 引用元論文 349 件、この内訳の 3.4%オーストラリア: 引用元論文 310 件、この内訳の 3%スペイン: 引用元論文 278 件、この内訳の 2.7%
0%15.1%その他 25.9%

分野

  • Medicine85.2%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Engineering1.1%
  • Immunology and Microbiology1%
  • Computer Science1%
  • Physics and Astronomy0.6%
  • その他2.5%

トピック

  • Prostate Cancer Diagnosis and Treatment20%
  • Prostate Cancer Treatment and Research19.8%
  • Radiopharmaceutical Chemistry and Applications4%
  • Advanced Radiotherapy Techniques3.4%
  • Urologic and reproductive health conditions2.1%
  • Cancer, Lipids, and Metabolism1.9%
  • その他48.8%

共著者

全論文

検索で開く
  1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 被引用: 2,814

  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Derya Tilki - European Urology 2024 被引用: 1,087

  3. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Burt Nabors, David A. Reardon, Martin J. van den Bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller - The Lancet Oncology 2014 被引用: 1,019

  4. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 被引用: 1,126

  5. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    著者: , , , , , , , , , , , , , , , , , , , , , - European Urology 2016 被引用: 3,260

  6. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2018 被引用: 517

  7. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip Cornford - European Urology 2024 被引用: 313

  8. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , - Annals of Oncology 2011 被引用: 249

  9. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , - European Urology 2016 被引用: 1,442

  10. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review

    著者: , , , , , , , , , , , , , , , , , , , , , - European Urology 2017 被引用: 533

  11. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Urology Focus 2019 被引用: 242

  12. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 被引用: 643

  13. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2017 被引用: 390

  14. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , - European Urology 2013 被引用: 1,354

  15. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Gross, Jeremy Grummet, Ann Henry, Alexandre Ingels, Jacques Irani, Michael Lardas, Matthew Liew, Daniel W. Lin, Lisa Moris, Muhammad Imran Omar, Karl H. Pang, Catherine Paterson, Raphaële Renard‐Penna, María J. Ribal, Monique J. Roobol, Morgan Rouprêt, Olivier Rouvière, Gemma Sancho, Jonathan Richenberg, Ivo G. Schoots, J.P. Michiel Sedelaar, Phillip D. Stricker, Derya Tilki, Susanne Vahr Lauridsen, Roderick C.N. van den Bergh, Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Geert J.L.H. van Leenders, Murali Varma, Philippe D. Violette, Christopher J.D. Wallis, Thomas Wiegel, Karen Wilkinson, Fabio Zattoni, James Michael Olu N'Dow, Hendrik Van Poppel, Philip Cornford, Nicolas Mottet - European Urology 2019 被引用: 239

  16. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 110

  17. EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

    著者: , , , , , , , , , , - European Urology 2013 被引用: 1,940

  18. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Cathy Yuhong Yuan, Philip Cornford, Nicolas Mottet, Thomas Lam - European Urology 2021 被引用: 102

  19. PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial

    著者: , , , , , , , , , , , , , , , - Cancers 2021 被引用: 49

  20. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Mottet, Thomas Wiegel - European Urology 2020 被引用: 146

  21. The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2023 被引用: 24

  22. Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

    著者: , , , , , , , , , , , , , , , , , , , , - European Urology 2014 被引用: 446

  23. Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature

    著者: , , , , , , - European Urology 2011 被引用: 287

  24. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2017 被引用: 259